"It’s now two years since the World Health Organization began calling the
COVID-19 outbreak a pandemic.
Two years ago, it was unclear whether it would even be possible to develop an
effective vaccine or treatment for the novel coronavirus. In the interim, we’ve
seen enormous scientific advances made in record time, bringing not one but
several vaccines, and a range of treatments, to the market.
But access to vaccines is still extremely uneven across the world. And now
similar problems are emerging with inequitable access to COVID-19 treatments.
Meanwhile, negotiations at the World Trade Organization (WTO) for a waiver of
intellectual property rights for COVID-19 health products and technologies,
underway for almost 18 months, are still in a state of paralysis. And there is
a risk that any agreement reached at the WTO might only apply to vaccines,
leaving treatments unavailable or unaffordable for around half the global
*** Xanni ***
Chief Scientist, Xanadu
Partner, Glass Wings
Manager, Serious Cybernetics